Be Ready.
When Minutes Matter.

Pathogen Reduced Cryoprecipitated Fibrinogen Complex

prepared from the

INTERCEPT® Blood System for Cryoprecipitation

Pathogen Reduced Cryoprecipitated Fibrinogen Complex (Fibrinogen Complex) is now FDA approved for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.

Emergency Medical Response Team

Hemorrhage is a leading cause
of preventable death1

Hemorrhage increases mortality risk in trauma,2,3 cardiac surgery,4 and childbirth.5

Faster is better in
hemorrhage control

Every effort should be made to decrease the time to
administration of the first blood products.6

INTERCEPT® Fibrinogen Complex

The ready-to-use* pathogen reduced, fibrinogen enriched blood component is approved specifically for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.7